Wu Y et al. designed an engineered bacterium capable of releasing interleukin-15 and interleukin-15 receptor α in response to temperature changes after microwave ablation treatment, which effectively inhibits tumour growth and prolongs animal survival even when microwave ablation is incomplete (Wu et al., 2024). This evidence concerns the gene IL15 and neoplasm.